Skip to main navigation Skip to search Skip to main content

Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer

  • Ignace Vergote
  • , Neil J. Finkler
  • , James B. Hall
  • , Ostap Melnyk
  • , Robert P. Edwards
  • , Marsha Jones
  • , James G. Keck
  • , Lisa Meng
  • , Gail L. Brown
  • , Elaine M. Rankin
  • , James J. Burke
  • , Ralph V. Boccia
  • , Carolyn D. Runowicz
  • , Peter G. Rose

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer'. Together they form a unique fingerprint.
    Sort by

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science

    Medicine and Dentistry